(19)
(11) EP 0 815 229 A2

(12)

(43) Date of publication:
07.01.1998 Bulletin 1998/02

(21) Application number: 96911399.0

(22) Date of filing: 21.03.1996
(51) International Patent Classification (IPC): 
G01N 33/ 53( . )
A61K 39/ 395( . )
A61P 35/ 00( . )
C07K 14/ 47( . )
C12N 5/ 10( . )
C12N 15/ 09( . )
C12P 21/ 02( . )
A61K 38/ 00( . )
A61K 48/ 00( . )
A61P 43/ 00( . )
C07K 14/ 705( . )
C12N 15/ 00( . )
C12N 15/ 12( . )
C12R 1/ 91( . )
(86) International application number:
PCT/US1996/004037
(87) International publication number:
WO 1996/029409 (26.09.1996 Gazette 1996/43)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 21.03.1995 US 19950408015
20.09.1995 US 19950530569

(71) Applicants:
  • LUDWIG INSTITUTE FOR CANCER RESEARCH
    New York, New York 10105 (US)
  • LEIDEN UNIVERSITY
    2300 RA Leiden (NL)

(72) Inventors:
  • GAUGLER, Beatrice, Inst.Ludwig p.l.Rech.s.l.Cancer
    B-1200 Brussels (BE)
  • VAN DEN EYNDE, Benoit, Inst.Ludwig plRech.slCancer
    B-1200 Brussels (BE)
  • SCHRIER, Peter
    NL-2312 AV Leiden (NL)
  • BROUWENSTIJN, Nathalie
    NL-2312 AV Leiden (NL)
  • BOON-FALLEUR, Thierry, Inst.Ludwig pl Rech.Cancer
    B-1200 Brussels (BE)

(74) Representative: Jump, Timothy John Simon, et al 
Venner Shipley & Co. 20 Little Britain
London EC1A 7DH
London EC1A 7DH (GB)

   


(54) RAGE TUMOR REJECTION ANTIGENS